PMID: 488565Aug 1, 1979Paper

Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats

Diabetologia
W BachmannH Mehnert

Abstract

Six to 12 hr after IP injection of 400 mg/kg of D-galactosamine in rats a 5-fold increase in plasma insulin was observed. In addition, impaired glucose assimilation was present after an IV Load in spite of unchanged fasting glucose levels. In streptozotocin-diabetic rats (100 mg/kg IV) plasma insulin remained diminished 12 h after induction of D-galactosamine hepatitis. Under identical conditions of preparation and incubation, the liver plasma membranes of D-galactosamine-treated rats, in both normal and diabetic states, bound only 40--60% as much insulin per mg of membrane protein as those of the control rats. Scatchard analysis suggested that this was due to a decrease in the number of receptor sites in the membranes of the D-galactosamine-injected rats. No difference in the insulin degrading capacity and in insulin-receptor dissociation of the plasma membranes between control and D-galactosamine-treated groups was found. These data suggest that a reduction in the number of hepatic insulin receptors in galactosamine hepatitis can lead to insulin resistance and hyperinsulinaemia.

References

Jan 1, 1977·The Journal of Clinical Investigation·M B Davidson, S A Kaplan
Mar 1, 1975·Diabetes·V Chandramouli, J R Carter
Mar 25, 1975·Biochimica Et Biophysica Acta·R H Michell
Jun 1, 1976·Experimental and Molecular Pathology·S M Sabesin, R S Koff
Jul 1, 1978·The Journal of Clinical Investigation·R A DeFronzoP Felig
Aug 8, 1977·Biochemical and Biophysical Research Communications·S JacobsP Cuatrecasas
Nov 22, 1965·Biochemical and Biophysical Research Communications·R H Michell, J N Hawthorne
Jan 6, 1970·Biochimica Et Biophysica Acta·T K Ray
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·P Cuatrecasas, G P Tell
Mar 1, 1973·European Journal of Clinical Investigation·C O Record, K G Alberti
Nov 1, 1973·Clinical Science and Molecular Medicine·C O RecordR Wright
Apr 1, 1970·Experimental and Molecular Pathology·A MedlineH Popper
Oct 1, 1968·Experimental and Molecular Pathology·D KepplerK Decker
Oct 1, 1965·The Journal of Clinical Endocrinology and Metabolism·V HerbertS J Bleicher
Oct 1, 1960·The Journal of Biophysical and Biochemical Cytology·D M NEVILLE
Jul 1, 1960·The Journal of Clinical Investigation·R S YALOW, S A BERSON
Dec 1, 1961·Klinische Wochenschrift·F H SCHMIDT

❮ Previous
Next ❯

Citations

Jan 1, 1985·Acta Paediatrica Scandinavica. Supplement·A AnderssonI Swenne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.